AI in drug discovery & development: News watch, October 2026
Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.
Newsletters and Deep Dive digital magazine
Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.
Stronger data analytics is cutting the number of questions regulators ask about intensified processes.
An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.
Zealand has added another strand to its programme of weight-loss drug development, linking with AI player Generate on multispecific protein therapies.
Robbie Tyrie, founder and managing director of Torridon Cyber, talks cybersecurity when it comes to AI, pharma companies, and health systems.
Editor's Picks
Newsletters and Deep Dive
digital magazine